Claude Sonnet 6 Odds Collapse 25 Cents in a Day: Is Anthropic's Release Firehose Running Dry?
Claude Sonnet 6 prediction market odds collapsed 25 cents in one day to 66¢. We break down Anthropic's release cadence, Risk Report data, and the honest case for both sides.
TL;DR
- The Polymarket contract on a new Claude Sonnet release by year-end dropped 25 cents in a single day, from 91¢ to 66¢ at press time.
- Anthropic shipped four major model releases in 76 days this summer, then went quiet for 40 days — and the market appears to be pricing that silence.
- Anthropic's own August 2026 Risk Report shows its best model (Mythos 5) scoring 50.3% on an internal research benchmark that requires 85% before models can substitute for human Research Scientists.
- The YES side still holds at 66¢, which means the market still leans toward another Sonnet before 2027 — just far less confidently than yesterday.
What the Market Says
One day ago, the prediction market on whether Anthropic would ship a next-generation Claude Sonnet model before December 31, 2026, was pricing YES at 91 cents. As of 2026-08-15 10:05 UTC, that same contract sits at 66 cents. The NO side, which would pay out if no new Sonnet ships by year-end, has moved from 9 cents to 34 cents overnight.
Twenty-four-hour volume was $160 — thin, but directional moves on low-volume markets often reflect conviction by the people paying closest attention, not noise. A 25-cent single-session drop is not a rounding error.
The contract resolves December 31, 2026. That gives Anthropic roughly four and a half months.
The Case
To understand the repricing, it helps to lay out what Anthropic has actually done this summer — and what it has not done since.
Between late May and early August 2026, Anthropic released five major model versions across what appears to be three distinct product families. Claude Sonnet 5 launched on August 6, 2026, though it had been set as the default model as early as July 1. Before that: Claude Opus 5 on July 24, Claude Mythos 5 and Claude Fable 5 on June 9, and Claude Opus 4.8 on May 28. Four major releases in 76 days — one every 19 days on average.
Then nothing for 40 days.
That gap is doing heavy lifting in the market's current pricing. Traders appear to be reading the post-Sonnet 5 silence as a signal that the near-term release pipeline has been cleared, not as a routine pause between model cycles.
There is a structural argument supporting that read. Anthropic's August 2026 Risk Report, covered by Moneycontrol on August 15 at 04:32 UTC, frames the company's pace of progress carefully. The report describes "meaningful acceleration starting in early-to-mid 2025, though by less than a factor of 2." Crucially, the pace remains below the Responsible Scaling Policy threshold, which would trigger additional review if acceleration hit 2x. The company is moving fast — just not so fast that its own safety protocols require escalation.
What the Risk Report also reveals is where the frontier actually sits internally. Claude Mythos 5 and the internally designated "Model 2" are described as extensively used for Anthropic's own R&D. Claude now authors "a large majority of the code merged into production codebases." And yet: Mythos 5 scores 50.3% on Anthropic's internal CoBench evaluation, an assessment of research-scientist-level capability. The threshold at which models could meaningfully substitute for human Research Scientists is 85%. The gap between 50.3% and 85% is not a rounding difference — it is a substantive reminder that the release cadence is outpacing capability completeness, at least by Anthropic's own measurement framework.
"Anthropic currently rates the overall risk from automated R&D as low. However, the company says it is less confident in this assessment than in previous reports because some of its task-based evaluations have reached a point where they no longer capture increases in model capabilities." — Anthropic Risk Report, August 2026, via Moneycontrol
That last clause deserves a beat: their benchmarks are becoming unreliable at the top end. Anthropic is not hiding this; it is publishing it. But it adds ambiguity to the question of whether a Sonnet 6 — or a Sonnet 5.5 with meaningfully improved agentic capabilities — is months away or right around the corner.
Meanwhile, on the competitive landscape, DeFi Rate's August 14 roundup of AI model odds and predictions notes that Anthropic still holds the top position on the Artificial Analysis Intelligence Index, with Claude Fable 5 leading the rankings. OpenAI's GPT-5.6, Moonshot's Kimi K3, and xAI's Grok 4.5 have gained ground without displacing the leader. Competitive pressure does not appear to have eased — which is one reason the market has not moved all the way to NO.
The most charitable read of the summer blitz is that it was pipeline-driven: five models were ready, so five models shipped. The less charitable read is that it was PR-timed — a demonstration of capability across multiple product families ahead of a planned consolidation and safety-reporting cycle. The 40-day silence since Opus 5 is consistent with the second interpretation.
Sonnet is Anthropic's workhorse tier. It is the model most developers build on, the one most consumers encounter through third-party integrations, and the one with the strongest commercial incentive to update. If Sonnet 5 has meaningful limitations — particularly in agentic task performance, which the Risk Report implies is still well below human-researcher substitution — then demand for Sonnet 6 or a Sonnet 5.5 variant will not wait for Anthropic's preferred cadence.
Risks
The NO position is now priced at 34 cents, which implies roughly a one-in-three chance that Anthropic ships nothing new in the Sonnet line for over four months. That is not an unreasonable probability, but it carries its own set of risks for anyone holding NO.
The release-cycle math cuts both ways. The gap between Sonnet 4.6 and Sonnet 5 was approximately 5.5 months. If that cadence repeats, a Sonnet 6 release in January 2027 would miss the December 31 resolution date by days — and the NO position would cash at 34 cents. But if Anthropic compresses the cycle even modestly, or if competitive pressure from OpenAI or xAI forces an earlier response, a Sonnet 5.5 or Sonnet 6 could ship well before year-end.
The August lull may be just that. A 40-day gap after a burst of five releases is not a trend; it is a data point. Anthropic could return to a faster cadence in September or October, and a single press release would reprice this contract back toward 90 cents overnight. Traders who moved to NO on the basis of one quiet month may find themselves on the wrong side of a fast-moving announcement.
Roadmap risk is underpriced in low-volume markets. At $160 in 24-hour volume, this market can be moved by a handful of informed traders — or corrected sharply by new public information. Any Anthropic developer conference, keynote appearance, or accidental model-card leak could shift the YES/NO balance within hours. The current 66¢ price should be read as a snapshot of a thin market, not a deep consensus.
Sonnet is a commercial product. Academic-style safety cycles apply to frontier research models. Sonnet exists to generate revenue. The commercial logic for an updated Sonnet before Q1 2027 — particularly one with improved agentic capabilities and better coding benchmarks — is straightforward. Anthropic's engineers may not be waiting for the safety team's full review cycle to ship an update to their most widely deployed model tier.
The 25-cent drop is a real signal. It is also a single day's movement in a low-volume market, and December 31 is a long way off. The honest position is that 66¢ is probably in the right neighborhood — but the error bars around it are wide.
Prices captured at press time and are not live. Not financial advice.
Every price in this piece was captured 2026-08-15 10:05 UTC. Odds move; the analysis may not age with them. Not financial advice.